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The protozoan parasite Trypanosoma cruzi causes Chagas disease, one of the major
neglected infectious diseases. It has the potential to infect any nucleated mammalian
cell. The secreted/excreted protein repertoire released by T. cruzi trypomastigotes is
crucial in host-pathogen interactions. In this study, mammalian tissue culture-derived
trypomastigotes (Y strain) were used to characterize the exoproteome of the infective
bloodstream life form. Proteins released into the serum-free culture medium after 3 h
of incubation were harvested and digested with trypsin. NanoLC-MS/MS analysis
resulted in the identification of 540 proteins, the largest set of released proteins
identified to date in Trypanosoma spp. Bioinformatic analysis predicted most identified
proteins as secreted, predominantly by non-classical pathways, and involved in host-cell
infection. Some proteins possess predicted GPI-anchor signals, these being mostly
trans-sialidases, mucin associated surface proteins and surface glycoproteins. Moreover,
we enriched phosphopeptides and glycopeptides from tryptic digests. The majority
of identified glycoproteins are trans-sialidases and surface glycoproteins involved in
host-parasite interaction. Conversely, most identified phosphoproteins have no Gene
Ontology classification. The existence of various proteins related to similar functions in the
exoproteome likely reflects this parasite’s enhanced mechanisms for adhesion, invasion,
and internalization of different host-cell types, and escape from immune defenses.
Keywords: Chagas disease, trypanosome, bloodstream trypomastigote, secretome, glycoprotein, phosphoprotein
INTRODUCTION
Adhesion and invasion are the first stages of interaction between an obligate intracellular
pathogen and its host-cell that involve cell surface molecules and secreted molecules.
The released molecules from infectious microorganisms may also play a crucial role in
pathogen life cycle and establishment of infection, such as host-defense evasion, migration
across host-tissues, cell adhesion, cell-cell communication, differentiation, proliferation, and
morphogenesis (Ranganathan and Garg, 2009; Soblik et al., 2011). Besides the classical secretory
pathway (Schatz and Dobberstein, 1996), several functional proteins are released into the
extracellular medium despite lacking any predicted signal peptides, thereby proving the existence
of unconventional mechanisms of protein secretion in eukaryotes (Nickel and Rabouille, 2009).
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The term secretome was first introduced in a bioinformatic
survey of proteins secreted by Bacillus subtilis (Tjalsma et al.,
2000). The authors defined the secretome as the subset
of the proteome, which is secreted, in addition to the
components of cellular machinery used for protein secretion.
The characterization of the B. subtilis secretome using a
proteomic approach showed that the genome-based prediction
correctly identified ∼50% of the proteins (Antelmann et al.,
2001). By comparison, the secreted proteins encoded by the
human genome represent approximately 30% of proteins (Skach,
2007). Nowadays the term secretome is used primarily to
denote proteins secreted by cells into the extracellular region
(Greenbaum et al., 2001). However, these released proteins
are not only secreted proteins but also proteins that arise
from other export mechanisms. Moreover, only those proteins
that are stable in the extracellular medium will remain in
abundance. Consequently, the best term to describe the protein
content found in the extracellular proximity of a given
biological system is the “exoproteome” (Armengaud et al.,
2012).
The protozoan Trypanosoma cruzi is responsible for Chagas
disease, which represents a major health public burden mostly in
Latin America. It is estimated that about 6 to 7 milion people are
infected (WHO, 2016). However, the epidemiological profile of
the disease has changed in recent years due to migration, with
thousands of patients in North America, Europe, Australia, and
Japan (Gascon et al., 2010). The treatment of Chagas disease
is currently based on chemotherapy, and no effective vaccine
is available. The unique drugs used against Chagas disease,
benznidazole, and nifurtimox, have high toxicity and the efficacy
of the treatment declines with time of infection (WHO, 2016).
Although their indication was until recently limited to the acute
phase, recent studies agree to treat patients in the chronic phase
(Lescure et al., 2010).
In order to carry out its lifecycle, the non-replicative and most
infective life form of T. cruzi, the metacyclic trypomastigote,
must cross the mammalian host’s extracellular matrix, adhere
to the cellular plasma membrane and can penetrate almost any
nucleated vertebrate host-cell by a non-conventional endocytic
mechanism involving host-cell lysosome recruitment and their
fusion with the parasitophorous vacuole. It results in an
obligatory stay in an acidic vacuole where the differentiation
into the replicative amastigote form (first amastigogenesis) is
initiated, and completed in the cytoplasm after escaping the
parasitophorous vacuole (Andrade and Andrews, 2004). After
replication, amastigotes can differentiate into tissue derived
bloodstream trypomastigotes released into the bloodstream
that can infect other vertebrate host-cell and the secondary
amastigogenesis is observed or be ingested by the blood-sucking
triatomine vectors (Vanhamme and Pays, 1995). In some cases,
amastigotes may be generated extracellularly, and they are
also able to infect cells (Mortara et al., 2008). Recently, a
quantitative high-throughput proteomic and phosphoproteomic
survey of T. cruzi axenic acidic-pH induced differentiation from
trypomastigotes into axenic amastigotes provided insights into
the molecular mechanisms coordinating this process (Queiroz
et al., 2014).
The infection involves a number of parasite
secretion/excretion factors, as well the release of host-membrane
binding proteins to allow infection and virulence. Some
mechanisms of host-cell invasion by T. cruzi have been described
at the ultrastructural level and the biochemical strategies
involved in host-parasite interaction have also been investigated
(Osuna et al., 1990; Tardieux et al., 1994; Di Noia et al., 1996;
Villalta et al., 2001; Ferreira et al., 2006). These mechanisms
involve an increase of host-cytosolic Ca2+ concentration caused
by the release of intracellular deposits of the ion during the
parasite invasion (Osuna et al., 1986; Rodríguez et al., 1996;
Pollevick et al., 2000). After the depolymerization of actin
filaments and recruitment of lysosomes toward the plasma
membrane by a kinesin-dependent process, it occurs the
remodeling of the host-cell cytoskeleton (Osuna et al., 1986;
Yoshida et al., 1989; Tardieux et al., 1994; Rodríguez et al., 1996;
Villalta et al., 2001; Tarleton et al., 2007). In the past 20 years
many groups have sought to identify the T. cruzi components
involved in host-cell invasion. The image emerging from these
studies is that the parasite’s penetration into the mammalian
cell is a multistep process involving several molecules from the
parasite and host in a series of events leading to intracellular
Ca2+ mobilization in both organisms (Burleigh and Andrews,
1998; Yoshida and Cortez, 2008). To invade mammalian cells,
metacyclic trypomastigotes employ surface glycoproteins, such
as gp82, gp35/50, or gp30 (a variant from gp82 expressed in
isolates deficient of gp82), mucins and trans-sialidases (TS)
(Buscaglia et al., 2006; Yoshida and Cortez, 2008; De Pablos et al.,
2011). These parasites can also use other components, such as
secreted proteins from the SAP family (proteins rich in serine,
alanine, and proline) (Baida et al., 2006). Trypomastigotes also
use a series of components to traverse the extracellular matrix
and invade the host-cell, such as Tc-85, gp83, Tc-1, cruzipain,
oligopeptidase B (OPBTc), and prolyl oligopeptidase 80 kDa
(POP Tc80) (Burleigh and Andrews, 1998; Yoshida and Cortez,
2008). For example, POP Tc80 is able to degrade native collagen
fibers in rat mesentery (Santana et al., 1997) and it could be
secreted despite having no secretion signal sequence (Grellier
et al., 2001; Bastos et al., 2013). OPBTc is active as a dimer
(Motta et al., 2012) and assists in cell invasion by generating
agonist modulators of Ca2+ required for the recruitment and
fusion of lysosomes to the parasite adhesion site (Tardieux et al.,
1992). In fact, the invasion of non-phagocytic cells is an active
process and the cell contact generates Ca2+ signaling modulating
factors from the parasite and/or host-cell, however the host-cell
signaling pathways activated by the protozoan have not yet
been fully identified (Burleigh and Andrews, 1998; Yoshida and
Cortez, 2008; Caradonna and Burleigh, 2011).
Today, high-resolution mass spectrometry-based proteomic
approaches have modified the view of exoproteomes. For
instance, recent secretome analyses regarding T. cruzi Dm28c
clone metacyclic trypomastigote and epimastigote (Bayer-Santos
et al., 2013) and also other members of the Kinetoplastida order
(Leishmania (Leishmania) donovani, Trypanosoma congolense
and T. evansi) (Silverman et al., 2008; Cuervo et al., 2009;
Geiger et al., 2010) have begun to unveil the links between
the high diversity of secreted molecular components and their
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functions. Although, metacyclic trypomastigotes and tissue
derived bloodstream trypomastigotes share some morphological
and biological properties, both forms display different modes
of interaction with host-cells (Burleigh and Andrews, 1995).
Since our interest is to better understand the infection of
the vertebrate host-cell by T. cruzi, the present investigation
is the first to perform such analysis of a T. cruzi Y strain
tissue derived trypomastigote (bloodstream form) exoproteome.
Furthermore, we performed glycopeptide and phosphopeptide
enrichment techniques to have a first glimpse of the post-
translational modifications (PTMs) present in secreted/excreted
proteins (Bendtsen et al., 2004; Conesa et al., 2005; Poisson et al.,
2007; Petersen et al., 2011).
MATERIALS AND METHODS
All reagents were from Sigma/Aldrich (St. Louis, USA) unless
stated otherwise.
Trypomastigote Cell Culture
Trypomastigotes, Y strain, were maintained in monolayers
of HeLa cells grown in Dulbecco’s Modified Eagle’s medium
(DMEM), pH 7.4, supplemented with 5% fetal bovine serum
(Sorali Biotecnologia, Campo Grande, Brazil) and 100 µg/mL
gentamicin, at 37◦C in an atmosphere with 5% CO2 (Andrews
andColli, 1982), with themedium changed daily within the initial
3 days after infection. Parasites emerged from the destroyed host-
cells from the 4th day and were collected on the 5th day, and
consisted of over 98% trypomastigotes.
Incubation and Processing of the
Exoproteome
Trypomastigotes were washed 3 times by centrifugation at 2500
× g for 10 min with DMEM, pH 7.4, without serum. Then, 1.0×
109 washed parasites were resuspended in 5 mL DMEM without
serum, pH 7.4, (2.0 × 108 cells/mL) as described in Queiroz
et al. (2013) and incubated in 25 cm2 culture flasks at 37◦C for
3 h, with gentle shaking every 20 min. After incubation, parasite
motility was checked and the sample was collected only if the
medium was not acidified and about 95% of the cells remained
mobile. To remove cells after the incubation, the medium was
centrifuged for 5 min at room temperature 3 times to ensure
complete removal of cells and avoid mechanical cell lysis: Firstly
at 2000 × g, then at 4000 × g, and finally at 6000 × g, with the
supernatants transferred to new tubes after each centrifugation.
After cell removal, proteins were precipitated with trichloroacetic
acid (TCA, 15% v/v) for 1 h at −20◦C and washed 3 times with
ice-cold acetone, at 14,000× g, 15 min, at 4◦C.
Sample Preparation
From one biological sample, TCA-precipitated proteins were
resuspended in 20 mM triethylammonium bicarbonate (TEAB),
reduced with 20 mM dithiothreitol at 56◦C for 45 min, alkylated
with 40 mM iodoacetamide at room temperature in the dark
for 60 min and digested overnight at 37◦C with 1 µg modified
trypsin (Promega, Madison, USA). After digestion, the sample
was acidified to a final concentration of 0.1% trifluoroacetic
acid (TFA) and desalted with homemade microcolumns of
Poros Oligo R3 resin (PerSeptive Biosystems, Framingham,
USA) packed (1 cm long) in p200 tips (adapted from Gobom
et al., 1999). Prior to lyophilization, peptide concentration
was determined by amino acid analysis using a Biochrom 30
amino acid analyser (Biochrom, Cambridge, U.K.) following the
manufacturer’s protocol.
TiO2 Affinity Phosphopeptide Enrichment
Phosphopeptides were enriched in batch by TiO2-affinity as
described elsewhere (Jensen and Larsen, 2007) with minor
modifications. Briefly, the digested and desalted sample (around
20–30 µg) was resuspended in 1 M glycolic acid in 80% (v/v)
acetonitrile (ACN)/5% TFA (v/v) followed by addition of 0.3mg
of TiO2 beads (TitanSphere beads, GL Sciences, Tokyo, Japan)
before incubation under vigorous shaking for 10–15 min. Beads
were spun down and supernatant transferred to new microtubes.
Addition of TiO2 beads to the supernatants (using 0.2mg and,
later, 0.1mg of TiO2) was repeated another two times. The
TiO2 beads from the 3 rounds of enrichment were combined
and washed firstly with 80% ACN/1% TFA (v/v) and then
with 10% ACN/0.1% TFA (v/v) to remove non-phosphorylated
peptides bound to TiO2 in a hydrophilic interaction liquid
chromatography (HILIC) way. Phosphopeptides were then
eluted with ammonia solution (0.28%), pH 11, and lyophilized.
ZIC-HILIC Glycopeptide Enrichment
The combined flow-through and wash without phosphopeptides
were dried down, resuspended with 0.1% TFA, desalted and
lyophilized before submitted to glycopeptide enrichment and
Peptide-N-Glycosidase F (PNGase F) digestion as described
in Mysling et al. (2010) with minor modifications. Briefly
homemade Zwitterionic HILIC (SeQuant, Umeå, Sweden, 10
µm) microcolumns packed (1 cm long) in p200 tips, in
analogy from (Gobom et al., 1999), were manufactured prior
to enrichment. The packed microcolumn was first washed with
20 µL elution solution (5% formic acid), then equilibrated with
40 µL load/wash solution (80% ACN, 1%TFA). The sample
solubilized in 10 µL load/wash solution was applied into the
column using a 1 mL syringe, washed with 40 µL load/wash
solution and glycopeptides were eluted with 10 µL elution
solution and dried. The flow-through and wash were also
collected and combined. The N-linked glycan structures from the
glycopeptides were removed using 0.2 units of PNGase F in 50
mM TEAB.
HILIC Fractionation
The flow through and wash from the glycopeptide enrichment
step were combined and separated in seven fractions on a TSKGel
Amide 80 (Tosoh Bioscience, Stuttgart, Germany) HILIC HPLC
column (length: 15 cm, diameter: 2 mm, particle size: 3 µm)
essentially as described elsewhere (McNulty and Annan, 2008;
Queiroz et al., 2014).
LC–MS/MS and Data Analysis
Samples were analyzed by an EASY-nano LC system (Proxeon
Biosystems, Odense, Denmark) coupled online to an
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LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific,
Waltham, USA). Peptides from each fraction were loaded onto
a 18 cm fused silica emitter (75 µm inner diameter) packed
in-house with reverse phase capillary column ReproSil-Pur
C18-AQ 3 µm resin (Dr. Maisch GmbH, Germany) and eluted
using a gradient from 100% phase A (0.1% formic acid) to 35%
phase B (0.1% formic acid, 95% acetonitrile) for 210 min for
the phosphopeptide and glycopeptide enriched fractions and
77 min for each HILIC fraction, 35 to 100% phase B for 5 min
and 100% phase B for 8 min in (a total of 223 min and 90 min
at 250 nL/min). After each run, the column was washed with
90% phase B and re-equilibrated with phase A. Mass spectra
were acquired in positive ion mode applying data-dependent
automatic survey MS scan and tandem mass spectra (MS/MS)
acquisition. Each MS scan in the orbitrap (mass range of m/z
of 400–1800 and resolution 60,000) was followed by MS/MS of
the seven most intense ions in the LTQ. Fragmentation in the
LTQ was performed by Higher Energy Collisional Dissociation
and selected sequenced ions were dynamically excluded for 30
s. Raw data were viewed in Xcalibur v.2.1 (Thermo Scientific,
Waltham, USA). Data processing was performed using Proteome
Discoverer v.1.3 (Thermo Scientific, Waltham, USA). Raw files
were generated and these were submitted to searching using
Proteome Discoverer with in house Mascot v.2.3 algorithm
against T. cruzi downloaded (early 2012) using Database on
Demand tool (Reisinger and Martens, 2009) containing the
proteins of the parasite found in UniProt/SWISS-PROT and
UniProt/TrEMBL. Contaminant proteins (several types of
human keratins, BSA and porcine trypsin) were also added
to the database and all contaminant proteins identified were
manually removed from the result lists. The searches were
performed with the following parameters: MS accuracy 10
ppm, MS/MS accuracy 0.5 Da, trypsin digestion with up to 2
missed cleavage allowed, fixed carbamidomethyl modification
of cysteine and variable modification of oxidized methionine
as well phosphorylation of serine, threonine and tyrosine
residues or deamidation of asparagine for the phosphopeptide
or glycopeptide enriched fractions, respectively. Number of
proteins, protein groups and number of peptides were filtered for
false discovery rate (FDR) less than 1%, peptides with rank 1 and
proteins with at least 2 peptides (except for the phosphopeptide
or glycopeptide enriched samples) using Proteome Discoverer.
Only N-glycopeptides with deamidation sites within the PNGase
consensus sequence (N-X-S/T/C, X 6= P) and phosphopeptides
with pRS probability greater than 50% (Beausoleil et al., 2006)
were considered for further analysis. ProteinCenter software
(Thermo Scientific, Waltham, USA) was used to generate FASTA
formatted files of groups of proteins of interest. Better annotation
of the identified was acquired using Blast2GO software (http://
www.blast2go.com/b2ghome) using default parameters. SignalP
v.4.0 (http://www.cbs.dtu.dk/services/SignalP/) and SecretomeP
v.2.0 (http://www.cbs.dtu.dk/services/SecretomeP/) softwares
were used to predict proteins secreted by classical and non-
classical pathways, respectively, and FragAnchor (Poisson
et al., 2007) to assign predicted Glycosylphosphatidylinositol
(GPI)-anchored proteins. Transmembrane helices based on a
hidden Markov model (TMHMM) algorithm (http://www.cbs.
dtu.dk/services/TMHMM/) was used to predict the number of
transmembrane helixes in the protein sequences.
Data Availability
Mass spectrometer output files (Raw data), peptide and protein
identification files (MGF and MSF files) have been deposited
in a public repository—The PeptideAtlas database (http://
www.peptideatlas.org/PASS/PASS00621) under the dataset Tag
Tcruzi_Exoproteome_ and database identifier PASS00621.
RESULTS
Profiling the Trypomastigote Exoproteome
In the experimental conditions, for 3 h, trypomastigotes exhibited
normal motility and morphology. The quantification of protein
released by 1.0× 109 parasites was estimated at around 60 µg.
Taken together, the seven HILIC fractions yielded 540
protein groups identified in the trypomastigote exoproteome
(Supplemental Table S1). The prediction algorithms for secretion
through classical (SignalP) and non-classical (SecretomeP)
pathways demonstrate that almost 80% of all identified
proteins are indeed expected to be secreted, although most of
them by non-classical pathways (Figure 1 and Supplemental
Table S2). Only 15.3% of all identified proteins were predicted
to have the signal peptide, demonstrating that just a small
proportion of secreted proteins follow the classical endoplasmic
reticulum/Golgi-dependent pathway.
Ninety seven proteins had a predicted
Glycosylphosphatidylinositol (GPI)-anchor signal
(Supplemental Table S2), being mostly TSs, mucin associated
surface proteins (MASPs) and surface glycoproteins.
The TMHMM server predicted 87 proteins to have
transmembrane helices, with numbers of helices ranging
from 1 to 5. Most of these were members of the TS family or
mucins (Supplemental Table S2). The remaining are mostly
proteins known to be involved in infection, such as gp63 acid
protease (mainly GPI-anchored or secreted isoforms of this
FIGURE 1 | Relative abundance of proteins identified in the
trypomastigote exoproteome predicted to be secreted through
classical (SignalP algorithm) and non-classical (SecretomeP algorithm)
pathways.
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protein family) (d’Avila-Levy et al., 2014) and cruzipain, which is
secreted through the flagellar pocket (Murta et al., 1990). Others
are known to be immunogenic proteins and glycoproteins.
For example surface protein-2 is a trypomastigote-specific
protein localized on the flagellum near the cell body of the
trypomastigote form, as well as the putative surface protein TolT,
TolT3 (Quanquin et al., 1999). And also were identified proteins
with lectin domains, localized in the flagellar pocket membrane
and the Golgi complex of the parasite, such as antigenic lectin-2
(Macêdo et al., 2006).
GO Classification of the Trypomastigote
Exoproteome
From all identified proteins, 536 sequences were retrieved by
Blast2GO software (Supplementary Table S2), with 48 not
allocated in any GO category, most of which are hypothetical or
putative proteins. Generic GO Slim was used to summarize the
sub-categories of the identified protein groups.
The most frequent cellular function terms identified by GO
Slim were hydrolase activity (GO:0016787), mainly due to the
large number of TS superfamily members presented in the
exoproteome, “nucleotide binding” (GO:0000166) and “catalytic
activity” (GO:0003824) (Figure 2).
“Symbiosis, encompassing mutualism through parasitism”
(GO:0044403) was the most common GO Slim biological process
term, which reflects the exoproteome’s trend toward infection
and host-pathogen interaction related processes. This subset of
proteins, summarized in Table 1, has 229 and 4 members with
predicted “hydrolase” (GO:0016787) and “transferase activities”
(GO:0016740) respectively, and includes 185 members of the
TS superfamily. Also along with the proteins predicted to be
involved in this process, there are mucin-type glycoproteins,
known to be implicated in parasite protection, attachment and
the evasion of immune system (Campo et al., 2004). Other
proteins found were members of FL-160 surface antigen gene
family and complement regulatory proteins that inhibit the
formation of the alternative and classical C3 convertase, thus
preventing activation and amplification of the host-complement
cascade, contributing to make trypomastigotes highly resistant to
the lytic effects of vertebrate complement (Norris et al., 1997).
Among the Tc13 antigen family members we identified in the
trypomastigote exoproteome is the surface antigen PHGST#5
(gi|22209012|) which is supposed to act as a ligand, interacting
with a neurotransmitter receptor, the beta(1)-adrenergic receptor
(García et al., 2003).
A common feature among most of the proteins we identified
categorized in “Symbiosis, encompassing mutualism through
parasitism” is the Laminin G domain (pfam13385). This
domain belongs to the Concanavalin A-like lectin/glucanases
superfamily and they are usually Ca2+-mediated receptors
that can have binding sites for steroids, beta 1 integrins,
heparin, sulfatides, fibulin-1, and alpha-dystroglycans. Proteins
that contain Laminin G domains serve a variety of purposes
including signal transduction via cell-surface steroid receptors,
adhesion, migration, and differentiation through mediation of
cell adhesion molecules (Marchler-Bauer et al., 2009).
PTMs in Secreted/Excreted Proteins
The glycopeptide enriched fraction yielded 27 N-glycopeptides
encompassing 24 different glycoproteins and the phosphopeptide
enrichment yielded 48 phosphopeptides from 40 different
phosphoproteins (Supplemental Table S3). As a preliminary
qualitative study with relatively small starting sample amount,
the objective was to detect the existence of phosphorylation
events on secreted/excreted proteins and, thereafter, propose
which protein groups are likely to be regulated.We could observe
that the majority of the identified phosphoproteins are not
annotated.
The majority of the glycoproteins we identified in the
exoproteome are TS superfamily members or surface
glycoproteins and, thus, the major GO Slim function and
process categories are “hydrolase activity and Symbiosis,
encompassing mutualism through parasitism” (Figure 3).
FIGURE 2 | Gene Ontology categories for all protein groups present in T. cruzi trypomastigote exoproteome. Generic GO Slim was used to summarize the
sub-categories. (A) Molecular Function and (B) Biological Process.
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TABLE 1 | Summary of proteins categorized in “Symbiosis, encompassing mutualism through parasitism.”
Number of proteins Description (Uniprot) Description (Blast2GO)
4 85 kDa surface glycoprotein (T. cruzi) trans-sialidase
1 amastigote cytoplasmic antigen (T. cruzi) trans-
1 amastigote surface protein 4 (T. cruzi) trans-sialidase
1 amastigote surface protein-2 (T. cruzi) surface protein-2
1 c71 surface protein (T. cruzi) trans-sialidase
1 complement regulatory protein (T. cruzi) trans-sialidase
3 Flagellum-Associated Protein (T. cruzi) trans-sialidase
4 glycoprotein 82 kDa (T. cruzi) glycoprotein 82 kDa
4 putative complement regulatory protein (T. cruzi) complement regulatory protein
6 putative FL-160-CRP protein (T. cruzi) fl-160-crp protein
1 RecName: Full=85 kDa surface antigen; Flags: Precursor trans-
1 sialidase (T. cruzi) trans-sialidase
2 sialidase homolog (T. cruzi) trans-
1 surface antigen PHGST#5 (T. cruzi) trans-sialidase
5 surface glycoprotein (T. cruzi) trans-
1 surface glycoprotein GP90 (T. cruzi) trans-sialidase
1 surface glycoprotein Tc-85/11 (T. cruzi) trans-sialidase
1 surface glycoprotein Tc-85/16 (T. cruzi) trans-sialidase
1 surface glycoprotein Tc-85/32 (T. cruzi) trans-sialidase
1 surface glycoprotein Tc85-11 (T. cruzi) trans-sialidase
1 surface glycoprotein Tc85-45 (T. cruzi) 85 kDa surface glycoprotein
2 surface protein-2 (T. cruzi) surface protein-2
1 Tcc1j12.4 (T. cruzi) trans-sialidase
6 trans-sialidase (T.cruzi) trans-sialidase
1 trans-sialidase homolog (T. cruzi) trans-sialidase
177 trans-sialidase, putative (T.cruzi) trans- partial
1 trans-sialidase-like protein (T. cruzi) trans-
1 trypomastigote surface glycoprotein (T. cruzi) trans-
2 unknown (T. cruzi) trans-
DISCUSSION
Products secreted by cells play fundamental biological roles
and represent the primary interface between parasite and host-
cell. The identification of proteins involved in host-parasite
interactions is important not only to understand the biological
aspects of these interactions, but also to find molecules capable of
blocking parasite invasion and proliferation in the host.
Bioinformatic approaches are fast and permit the prediction
of secreted proteins by the presence of an N-terminal signal
peptide sequence. However, there is evidence that many secreted
proteins lack this signal peptide. Moreover, T. cruzi has
polycistronic transcription, following by a trans-splicing step,
and the regulation of gene expression for protein-coding genes
depends entirely on post-transcriptional processes (Michaeli,
2011). Therefore, transcriptomics is limited in its ability to
determine protein expression levels and post-transcriptional
modifications.
The lifecycle of T. cruzi is complex, with several life forms and
requires the expression of specialized proteins for the parasite’s
development and in order to circumvent the host immune
response. For successful infection, T. cruzi needs to adapt to
its new environment and choose the correct molecular tools
to counteract host-defenses. For example, in mammalian hosts,
bloodstream trypomastigotes try to escape the host immune
system by expressing glycoproteins on their surface, while in
the triatomines, they face the invertebrate host’s immune system,
intestinal proteases and antimicrobial compounds (Garcia et al.,
2010).
Previous investigations of the T. brucei gambiense secretome
identified 444 secreted proteins, the largest set of secreted
proteins presently characterized in Trypanosoma (Geiger et al.,
2010). And 367 proteins were reported to be released by
both metacyclic trypomastigote and epimastigote T. cruzi life
forms (Bayer-Santos et al., 2013). In this study, we found a
large number of proteins released into the medium by the
tissue culture cell-derived trypomastigote form (540 proteins),
using stringent mass spectrometry criteria to accept protein
identification (FDR <1%, only rank 1 peptide and at least 2
peptides per protein). It is noteworthy that in our study the
incubation time in the serum-free culture medium was 3 h,
as used for the Leishmania (Viannia) braziliensis secretome
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FIGURE 3 | Gene Ontology categories for N-linked glycoproteins present in T. cruzi trypomastigote exoproteome. Generic GO Slim was used to
summarize the sub-categories. (A) Molecular Function, (B) Biological Process.
by Cuervo and collaborators (Cuervo et al., 2009) to limit
the parasite exposure to environmental stress upon incubation
conditions. This reinforces the effectiveness of this approach,
which obtained a higher number of proteins in a considerably
short incubation.
The SignalP and SecretomeP algorithms were used to predict
whether the identified proteins were secreted by a classical
pathway (with signal peptide) or a non-classical pathway. These
analyses revealed that about 65% of the proteins were not
secreted by the classical pathway, a small portion (15%) by
the classical pathway, and the remaining with no predicted
pathway, in agreement with other kinetoplastids organisms
(Cuervo et al., 2009; Grebaut et al., 2009; Geiger et al., 2010).
The secreted protein profile of Leishmania (Viannia) braziliensis
promastigotes revealed that over 60% of identified proteins
were predicted to be secreted, with the vast majority (about
57%) predicted as going through non-classical pathways (Cuervo
et al., 2009). In the T. cruzi metacyclic trypomastigote and
epimastigote secretomes, the secretion was predicted to be
mostly via non-classical pathways (Bayer-Santos et al., 2013).
Recently, a detailed proteome description of the bloodstream
forms detected some proteins predicted to be secreted by non-
classical secretion pathway (Brunoro et al., 2015). All together,
these data indicate that protein export in lower eukaryotes was
primarily by unconventional pathways, which suggests that these
pathways play an important role in the release of extracellular
proteins by T. cruzi.
To better understand the possible role of the released
proteins, we used ProteinCenter and Blast2GO softwares to
assign GO Molecular Function, Biological Process, and Cellular
Compartment terms. Only 8 and 10% of the identified proteins
could not be assigned to any molecular function and biological
process, respectively. These proteins are good candidates for
further characterization.
Among the identified proteins, several have been
experimentally observed as released, for example the already
cited TS, mucins and MASP. Glycosylphosphatidylinositol
(GPI)-anchored proteins extensively coat the plasma membrane
of T. cruzi and are involved in many aspects of host-parasite
interactions, such as adhesion and invasion of host-cells, and
pathogenesis (Nakayasu et al., 2009). Although they are attached
to the plasma membrane by GPI anchors, enzymes such as
phosphatidylinositol phospholipase C might release them from
the anchors, as already reported for members of TS family
(Buscaglia et al., 2006). Components of this secreted/excreted
repertoire, which represent the most immunodominant antigens
in T. cruzi, have also been employed in the development of
diagnostic tests for Chagas disease (Matsumoto et al., 2002;
Berrizbeitia et al., 2006). TS and mucin protein families are
essential to the invasion process. They are anchored to the
parasite membrane and can be shed into the bloodstream. TS
bind host-cell receptors and can transfer sialic-acid residues from
host glycoconjugates to the major surface glycoproteins of T.
cruzi, mucin-like-proteins (Buscaglia et al., 2006). Also, some of
MASPs have been found in the membrane of the trypomastigotes
and/or secreted into the culture medium (De Pablos et al.,
2011).
Likewise, the calreticulin predicted as secreted through the
classical pathway, has been previously reported as a calcium
binding protein that controls calcium levels in ER and has an
important function in the parasite infectivity inactivating the
complement component C1 (Ramírez et al., 2011, 2012).
Another protein secreted by a non-classical pathway, is
superoxide dismutase. This enzyme has been suggested to be
involved in parasite defense mechanisms and the establishment
of trypanosome-host interaction (Kabiri and Steverding, 2001;
Villagrán et al., 2005).
Furthermore, T. cruzi parasites excrete molecules through
small vesicles at the flagellar pocket (e.g., exosomes) and larger
vesicles (ectosomes) (Bayer-Santos et al., 2013). Exosomes
possess a characterized mainstream protein composition
(Mathivanan et al., 2010), 15 members of which we identified
in the exoproteome: (i) the cytoskeletal proteins actin,
cofilin 1 and tubilins; (ii) the enzymes enolase 1, PGK1,
CNP, MDH 1, cyclophilin A, and peroxiredosins; (iii) the
signal transduction proteins mucin 1 and 14-3-3 protein;
(iv) the ATPase ATP5B; (v) ribosomal proteins and (vi)
ubiquitin.
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The release of such vesicles is a mode of unconventional
protein secretion that has received growing attention lately.
This kind of protein secretion has been correlated to autophagy
pathways that do not necessarily lead to complete degradation
of macromolecules (Manjithaya and Subramani, 2011).
Furthermore, protein released through vesicles offers advantages
such as protection against extracellular agents like proteases
and antibodies, avoiding modifications that would be acquired
when secreted through classical pathway and block normal
protein function (Wegehingel et al., 2008). And also it has been
demonstrated that these vesicles serve in cell-cell communication
(Mathivanan et al., 2010; Manjithaya and Subramani, 2011),
including in protozoan parasites (Regev-Rudzki et al., 2013),
and remain active during starvation, when the conventional
secretion is blocked (Shorer et al., 2005; Geng et al., 2010). For T.
cruzi, extracellular vesicles promoted metacyclogenesis and also
infection susceptibility of mammalian cells (Garcia-Silva et al.,
2014).
In addition, this study presents the first experimental
evidence of PTMs, such as N-glycosylation, and phosphorylation
for the trypomastigote exoproteome. PTMs regulate
the functional activity of proteins involved in different
biological processes. Protein phosphorylation is well-
recognized as a key PTM and recently, was demonstrated
that phosphorylation/dephosphorylation events coordinate
transformation of cell culture-derived trypomastigotes to axenic
amastigotes in vitro (Queiroz et al., 2014). The biological
relevance of the phosphorylation of released proteins remains to
be explored.
In 1991, Hall and Joiner wrote: “Investigation of the molecular
basis for the complex interplay between intracellular parasites
and host-cells is currently underway in a number of laboratories
and promises to provide exciting new insights for parasitologists,
immunologists, and cell biologists” (Hall and Joiner, 1991). More
than 30 years later, we could conclude that different intracellular
parasites, exemplified here by T. cruzi, use several secretion
strategies and the understanding of the recent exoproteome
data on pathogenic microorganisms is a challenge, limited
by experimental conditions and methods and the diversity of
identified proteins. In addition, a set of identified secreted
proteins with unknown functions may play important roles
in T. cruzi invasion and, thus, there is a need for future
functional characterization studies. Exoproteome analysis is still
a promising area of research providing insight into T. cruzi
infection; secreted proteins serve as a rich source of biomarkers
and the development of new therapeutic strategies.
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